Athenex Moves Forward With $205M New York Plant Post author:Sam Post published:January 11, 2018 Post category:BioPharma According to a SEC filing, the cost of the facility will be paid in part by the State of New York. Source: BioSpace You Might Also Like NOXXON Pharma AG Announces Prospectus Publication And Share Transfer To The Public Offering Compartment Of The Euronext Growth Market July 11, 2017 What Makes Biogen and Bristol-Myers Squibb Such Attractive Takeover Targets June 26, 2017 Lundbeck Names Interim Leader, Effective Nov. 1, 2017 October 30, 2017
NOXXON Pharma AG Announces Prospectus Publication And Share Transfer To The Public Offering Compartment Of The Euronext Growth Market July 11, 2017